IDXX Idexx Laboratories Inc
- Stocks
- Healthcare
- NASDAQ: IDXX
Price (delayed)
$650.84
Market cap
$52.07B
P/E Ratio
53.7
Dividend/share
N/A
EPS
$12.12
Enterprise value
$53.12B
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and
Highlights
The company's EPS rose by 19% YoY and by 11% QoQ
The company's net income rose by 17% YoY and by 10% QoQ
IDXX's price to earnings (P/E) is 27% higher than its last 4 quarters average of 42.3 but 2.5% lower than its 5-year quarterly average of 55.1
The quick ratio has decreased by 30% YoY and by 3.3% QoQ
The debt has grown by 17% from the previous quarter and by 16% YoY
Key stats
What are the main financial stats of IDXX
Market
Valuations
Earnings
Shares outstanding
80M
Market cap
$52.07B
Enterprise value
$53.12B
Price to earnings (P/E)
53.7
Price to book (P/B)
35.88
Price to sales (P/S)
12.96
EV/EBIT
42.09
EV/EBITDA
37.95
EV/Sales
13.16
Revenue
$4.04B
Gross profit
$2.48B
Operating income
$1.26B
Net income
$985.66M
EBIT
$1.26B
EBITDA
$1.4B
Free cash flow
$774.34M
Per share
Balance sheet
Liquidity
EPS
$12.12
EPS diluted
$12.01
Free cash flow per share
$9.63
Book value per share
$18.14
Revenue per share
$50.21
TBVPS
$34.98
Total assets
$3.33B
Total liabilities
$1.87B
Debt
$1.21B
Equity
$1.46B
Working capital
$138.48M
Debt to equity
0.83
Current ratio
1.11
Quick ratio
0.59
Net debt/EBITDA
0.75
Margins
Efficiency
Dividend
EBITDA margin
34.7%
Gross margin
61.5%
Net margin
24.4%
Operating margin
31.1%
Return on assets
29.9%
Return on equity
64.4%
Return on invested capital
50.7%
Return on capital employed
59.9%
Return on sales
31.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDXX stock price
How has the Idexx Laboratories stock price performed over time
Intraday
-0.48%
1 week
-1.1%
1 month
23.58%
1 year
34.05%
YTD
57.42%
QTD
21.35%
Financial performance
How have Idexx Laboratories's revenue and profit performed over time
Revenue
$4.04B
Gross profit
$2.48B
Operating income
$1.26B
Net income
$985.66M
Gross margin
61.5%
Net margin
24.4%
The company's net income rose by 17% YoY and by 10% QoQ
IDXX's operating income is up by 16% YoY and by 10% from the previous quarter
IDXX's operating margin is up by 9% YoY and by 7% QoQ
The gross profit has increased by 9% YoY and by 3.1% QoQ
Price vs fundamentals
How does IDXX's price correlate with its fundamentals
Growth
What is Idexx Laboratories's growth rate over time
Valuation
What is Idexx Laboratories stock price valuation
P/E
53.7
P/B
35.88
P/S
12.96
EV/EBIT
42.09
EV/EBITDA
37.95
EV/Sales
13.16
IDXX's price to earnings (P/E) is 27% higher than its last 4 quarters average of 42.3 but 2.5% lower than its 5-year quarterly average of 55.1
The company's EPS rose by 19% YoY and by 11% QoQ
The price to book (P/B) is 44% more than the last 4 quarters average of 25.0 but 26% less than the 5-year quarterly average of 48.8
The company's equity fell by 8% YoY
The P/S is 34% above the last 4 quarters average of 9.7 and 6% above the 5-year quarterly average of 12.2
IDXX's revenue is up by 7% year-on-year and by 2.7% since the previous quarter
Efficiency
How efficient is Idexx Laboratories business performance
The return on assets rose by 16% year-on-year and by 11% since the previous quarter
Idexx Laboratories's return on invested capital has increased by 14% YoY and by 7% QoQ
Idexx Laboratories's return on equity has increased by 13% YoY and by 12% QoQ
The company's return on sales rose by 8% YoY and by 6% QoQ
Dividends
What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDXX.
Financial health
How did Idexx Laboratories financials performed over time
The company's total assets is 78% higher than its total liabilities
The quick ratio has decreased by 30% YoY and by 3.3% QoQ
IDXX's current ratio is down by 19% year-on-year and by 4.3% since the previous quarter
The debt is 17% less than the equity
IDXX's debt to equity is up by 26% YoY and by 15% QoQ
The debt has grown by 17% from the previous quarter and by 16% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.